University of Michigan Finds New Target to Improve Response to Cancer Immunotherapy

May 3, 2019 | Cancer, Ferroptosis, Immunotherapy, Immunotherapy for Cancer

University of Michigan Rogel Cancer Center studied at a little-understood type of cell death called ferroptosis. They found ferroptosis occurs in tumor cells and impacts cancer immunity—possibly pointing to the potential of targeting this pathway to improve immunotherapy treatment as recently published in Nature

Lead Research/Investigator

Weiping Zou, MD, PhD, the Charles B. de Nancrede Professor of Surgery, Immunology, Biology & Pathology, University of Michigan


Pin It on Pinterest